Jonathan Violin

Insider Reports History

Location
Chesterbrook, PA
Signature
/s/ Barbara Bispham, as attorney-in-fact for Jonathan Violin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Violin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Common Stock 481K $10.1M $21.00 02 Feb 2023 Direct
GLYCOMIMETICS INC Director Ordinary Shares 69.5K $14.6K $0.21 13 Jun 2025 Direct
Viridian Therapeutics, Inc.\DE Chief Executive Officer, Director Stock Option (Right to Buy) 239K 02 Feb 2023 Direct
Astria Therapeutics, Inc. Director Stock Option (Right to Buy) 26.6K 11 Jun 2025 Direct
Dianthus Therapeutics, Inc. /DE/ Director Stock Option (Right to Buy) 12.5K 22 May 2025 Direct
GLYCOMIMETICS INC Director Stock Option (Right to Buy) 9.02K 23 Jun 2025 Direct

Insider Reports Filed by Jonathan Violin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CBIO GLYCOMIMETICS INC 23 Jun 2025 1 $0 4 Director 23 Jun 2025, 18:46
CBIO GLYCOMIMETICS INC 13 Jun 2025 0 $0 3 Director 23 Jun 2025, 18:23
ATXS Astria Therapeutics, Inc. 11 Jun 2025 1 $0 4 Director 12 Jun 2025, 19:11
DNTH Dianthus Therapeutics, Inc. /DE/ 22 May 2025 1 $0 4 Director 22 May 2025, 16:44
ATXS Astria Therapeutics, Inc. 05 Jun 2024 1 $0 4 Director 06 Jun 2024, 16:06
DNTH Dianthus Therapeutics, Inc. /DE/ 23 May 2024 1 $0 4 Director 28 May 2024, 20:02
MGTA Dianthus Therapeutics, Inc. /DE/ 11 Sep 2023 1 $0 4 Director 13 Sep 2023, 21:25
MGTA Dianthus Therapeutics, Inc. /DE/ 11 Sep 2023 0 $0 3 Director 13 Sep 2023, 20:46
ATXS Astria Therapeutics, Inc. 02 Jun 2023 1 $0 4 Director 06 Jun 2023, 08:06
VRDN Viridian Therapeutics, Inc.\DE 02 Feb 2023 3 -$1.83M 4/A Chief Executive Officer, Director 07 Feb 2023, 17:35
VRDN Viridian Therapeutics, Inc.\DE 02 Feb 2023 1 -$1.84M 4 Chief Executive Officer, Director 03 Feb 2023, 17:12
ATXS Astria Therapeutics, Inc. 09 Jun 2022 1 $0 4/A Director 21 Jun 2022, 08:33
VRDN Viridian Therapeutics, Inc.\DE 01 Jun 2022 1 -$366K 4 Chief Executive Officer, Director 02 Jun 2022, 17:29
VRDN Viridian Therapeutics, Inc.\DE 02 May 2022 1 -$391K 4 Chief Executive Officer, Director 04 May 2022, 17:23
VRDN Viridian Therapeutics, Inc.\DE 01 Apr 2022 2 -$568K 4 Chief Executive Officer, Director 05 Apr 2022, 18:09
VRDN Viridian Therapeutics, Inc.\DE 01 Mar 2022 2 -$529K 4 Chief Executive Officer, Director 03 Mar 2022, 15:48
VRDN Viridian Therapeutics, Inc.\DE 01 Feb 2022 4 -$573K 4 Chief Executive Officer, Director 03 Feb 2022, 17:11
VRDN Viridian Therapeutics, Inc.\DE 08 Dec 2021 2 $0 4 President and Chief Executive Officer Exhibit 24 - Power of Attorney, Director 10 Dec 2021, 17:08
ATXS Astria Therapeutics, Inc. 20 Sep 2021 2 $0 4 Director 22 Sep 2021, 17:00
ATXS CATABASIS PHARMACEUTICALS INC 02 Jun 2021 1 $0 4 Director 02 Jun 2021, 19:17